Immix Biopharma, Inc.
IMMX
$8.18
$0.172.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.44M | -23.56M | -23.13M | -20.90M | -21.61M |
| Total Depreciation and Amortization | 364.50K | 315.20K | 206.20K | 150.70K | 115.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.44M | 2.58M | 2.84M | 2.93M | 2.94M |
| Change in Net Operating Assets | 2.70M | 6.29M | 7.57M | 5.36M | 3.97M |
| Cash from Operations | -23.93M | -14.38M | -12.51M | -12.45M | -14.60M |
| Capital Expenditure | -732.90K | -1.08M | -974.00K | -943.50K | -1.18M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.48M | -- | -- | -- | -- |
| Cash from Investing | -7.21M | -1.08M | -974.00K | -943.50K | -1.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 107.52M | 11.89M | 1.11M | 0.00 | 15.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -137.00K | -166.80K | -- | -- | -- |
| Cash from Financing | 107.39M | 11.72M | 1.11M | 0.00 | 15.95M |
| Foreign Exchange rate Adjustments | 3.80K | -9.60K | 34.00K | -1.20K | -3.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.25M | -3.74M | -12.34M | -13.40M | 172.10K |